Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 12:45 AM
Study NCT ID:
NCT01253460
Status:
TERMINATED
Last Update Posted:
2019-09-06
First Post:
2010-12-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-08-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-13
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-01
First Submit QC Date:
None
Study First Post Date:
2010-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-27
Results First Submit QC Date:
None
Results First Post Date:
2019-09-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-15
Last Update Post Date:
2019-09-06
Last Update Post Date Type:
ACTUAL